1 Kaufman R M，Dulbegovic B，Gernsheimer T，et al.Platelet Transfusion: A Clinical Practice Guideline From the AABB[J].Ann Intern Med，2015，162（3）：205-213. 2 Guyatt G H，Oxman A D，Vist G E，et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ，2008，336（7650）：924-926. 3 Guyatt G H，Oxman A D，Kunz R，et al. GRADE Working Group Going from evidence to recommendations[J].BMJ，2008，336（7650）：1049-1051. 4 Mark K F，Brenda J G，Chrostopher D，et al.Technical mannual(18th edition)[M].AABB，2014. 5 The National Institute for Health and care excellence.NICE guidelines [NG24]：Blood transfusion[M].National clinical guideline centre，2015-11-18. 6 Miller A B，Hoogstraten B，Staquet M，et al.Reporti ng results of cancer treatment[J].Cancer，1981，47（1）：207-214. 7 Estcourt L J，Heddle N，Kaufman R，et al.Biomedical Excellence for Safer Transfusion Collaborative The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions[J].Transfusion，2013，53（7）：1531-1543. 8 Dijkstra-Tiekstra M J，van de WateringL M，Rondeel J M，et al. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation[J].Transfusion medicine，2014，24（2）：99-104. 9 Meesters M I，Veerhoek D，de Lange F，et al.Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial[J].Thromb Haemost，2016，116（2）：251-261. 10 McHugh S M，Kolarczyk L，Lang R S，et al.A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery[J].Indian J Anaesth，2016，60（2）：94-101. 11 Mazzeffi M，Lund L，Wallace K，et al.Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study[J].Perfusion，2016，31（6）：508-515. 12 Xie Y，Shen S，Zhang J，et al.The efficacy，safety andcost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial[J].Int J Med Sci，2015，12（4）：322-328. 13 Rolf Rossaint，Bertil Bouillon，Vladimir Cerny，et al.The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition[M].Crit Care，2016，20：100. 14 Klein A A，Arnold P，Bingham R M，et al.AAGBI guidelines: the use of blood components and their alternatives 2016.Anaesthesia[J]. 2016，71（7）：829-842. 15 D B，Brubaker C，Marcus E，Holmes. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets[J].American journal of hematology，1998，58（3）：165-176. 16 Gupta A，Chandra T，Kumar A.Retracted: Platelet storage lesion: current proteomics approach[J].Platelets，2011，22（4）：312-329. 17 Xin X，Liu Z，Jian C，et al.The role of thromboelasto graphy in predicting bleeding risk and guiding the administration of platelettransfusions in hematological patients: a cohort study[J].Ann Hematol，2016，95（7）：1163-1168. 18 Lyu M，Li Y，Xue F，et al.Application of immature platelet fraction absolute immature platelet fraction and thrombelastograph on assessment of bleeding risk in patients with immune thrombocytopenia[J].Zhonghua Xue Ye Xue Za Zhi，2015，36（9）：759-764. 19 Valeri C R，Cassidy G，Pivacek L E，et al.Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss[J].Transfusion，2001，41（8）：977-983. 20 林姝婷，赖冬，龙敏.血小板与冷沉淀联合输注在大出血临床治疗中应用的Meta分析[J].中外医学研究，2016，14（26）：1-4. 21 Helms C C，Marvel M，Zhao W，et al.Mechanisms of hemolysis-associated platelet activation[J].J Thromb Haemost，2013，11（12）：2148-2154. 22 Schwertz H，Rondina MT.Cdkn2a Orchestrates Platelet Production and Reactivity in Atherosclerosis[J].Circ Cardiovasc Genet，2016，9（3）：203-205. 23 Yang L，Cong H L，Wang S F，et al.AMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis[J].Exp Ther Med，2017，13（4）：1622-1629. 24Brand A.Immunological complications of blood transfusions[J].Presse Med， 2016，45（7-8 Pt 2）：e313-324. 25 Huang G，Hua S，Yang T，et al. Chen X.Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors[J].Exp Ther Med，2018，15（3）：3096-3102. 26 Middleton E A，Weyrich AS，Zimmerman GA.Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases[J].Physiol Rev，2016，96（4）：1211-1259. 27 Mahemuti A，Abudureheman K，Schiele F，et al.Association between inflammatory markers，hemostatic markers，and traditional risk factors on coronary artery spasm in patients with normal coronary angiography[J]. J Interv Cardiol，2014，27（1）：29-35. 28 Xu X R，Zhang D，Oswald B E，et al.Platelets are versatile cells: New discoveries in hemostasis，thrombosis，immune responses，tumor metastasis and beyond[J].Crit Rev Clin Lab Sci，2016，53（6）：409-430. 29 Jing L，Qu H，Wu D，et al.Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy[J].Theranostics，2018，8（10）：2683-2695.
